China Mechanism of Action Analysis of Medical-Grade Potassium Citrate (Citrate of Potash) - China Supplier
China Mechanism of Action Analysis of Medical-Grade Potassium Citrate (Citrate of Potash) - China Supplier China Mechanism of Action Analysis of Medical-Grade Potassium Citrate (Citrate of Potash) - China Supplier China Mechanism of Action Analysis of Medical-Grade Potassium Citrate (Citrate of Potash) - China Supplier

Mechanism of Action Analysis of Medical-Grade Potassium Citrate (Citrate of Potash)

Price:面谈
Industry Category: Chemicals
Product Category:
Brand: 华日
Spec: 500g/瓶


Contact Info
  • Add:莲湖区丰镐西路隆基大厦, Zip:
  • Contact: 王彤
  • Tel:18691883541
  • Email:731724677@qq.com

Other Products

Description
Additional Information

Analysis of the Mechanism of Action of Medical-Grade and Pharmaceutical-Grade Potassium Citrate


As a commonly used clinical drug, pharmaceutical-grade potassium citrate demonstrates significant efficacy in the treatment and prevention of various diseases. Its mechanism of action involves multiple physiological processes, which are detailed below.

1. Supplementing Potassium Ions and Correcting Hypokalemia

Potassium ions are important cations within human cells, playing a key role in maintaining normal cellular metabolism, neuromuscular excitability, and overall physiological function. Hypokalemia occurs when the body loses excessive potassium due to various reasons (such as inadequate intake, vomiting, diarrhea, or long-term use of potassium-wasting diuretics) or when potassium intake is insufficient. Hypokalemia can lead to a range of symptoms, including muscle weakness and arrhythmias.

After ingestion, pharmaceutical-grade potassium citrate dissociates into potassium ions in the gastrointestinal tract. These potassium ions enter the bloodstream through active transport and passive diffusion across the intestinal mucosa. They are then transported into cells, replenishing intracellular potassium deficits and restoring the balance of potassium concentrations inside and outside cells. This process corrects hypokalemia and restores normal neuromuscular excitability and cardiac rhythm.

2. Regulating Acid-Base Balance and Improving Renal Tubular Acidosis

Renal tubular acidosis results from impaired renal tubule function, reducing the kidneys' ability to regulate acid-base balance. This leads to the accumulation of acidic substances or loss of alkaline substances in the body, causing acidosis. In patients with type I distal renal tubular acidosis accompanied by hypokalemia, pharmaceutical-grade potassium citrate plays a crucial therapeutic role.

After metabolism in the body, the citrate ions from potassium citrate participate in the tricarboxylic acid cycle, ultimately oxidizing into carbon dioxide and water while generating bicarbonate ions (HCO₃⁻). Bicarbonate is an important alkaline substance that neutralizes excess acids in the body, increases blood pH, and corrects acidosis. Simultaneously, potassium supplementation helps improve the function of renal tubular cells, further promoting the restoration of acid-base balance.

3. Altering Urine Composition and Preventing Urinary System Stones

The formation of urinary stones is closely related to the concentration and solubility of various components in urine. Pharmaceutical-grade potassium citrate prevents urinary stones through the following mechanisms:

Inhibiting Calcium Oxalate Stone Formation: Calcium oxalate is one of the primary components of kidney stones. The citrate ions released from potassium citrate bind with calcium ions to form soluble calcium citrate complexes. This reduces the concentration of free calcium ions in urine, decreasing the chance of calcium ions combining with oxalate ions to form calcium oxalate crystals, thereby inhibiting stone formation. Additionally, calcium citrate complexes have high solubility and are less likely to precipitate, further preventing stone growth.

Dissolving Uric Acid Stones: Uric acid has low solubility in acidic urine and tends to crystallize into stones. After ingestion, pharmaceutical-grade potassium citrate increases urine pH, making it alkaline. In an alkaline environment, the solubility of uric acid significantly increases, leading to the gradual dissolution of existing uric acid stones, thus preventing and treating uric acid stones.

4. Influencing Electrophysiology and Alleviating Arrhythmias

In cases of arrhythmias caused by digitalis toxicity, pharmaceutical-grade potassium citrate can also provide therapeutic benefits. Potassium ions significantly impact the electrophysiological properties of myocardial cells. During hypokalemia, myocardial cell excitability increases, and automaticity is enhanced, making arrhythmias more likely. Supplementing with pharmaceutical-grade potassium citrate allows potassium ions to enter myocardial cells, restoring the resting membrane potential, reducing excitability and automaticity, and improving conduction function. This corrects arrhythmias caused by hypokalemia or digitalis toxicity, restoring normal rhythm.



Analysis of the Mechanism of Action of Medical-Grade and Pharmaceutical-Grade Potassium Citrate

Potassium citrate is an important pharmaceutical excipient widely used in the pharmaceutical industry. As an inorganic salt, it exhibits good solubility and biocompatibility, commonly serving as an acid-base regulator, chelating agent, and potassium supplement. According to the "Chinese Pharmacopoeia 2020 Edition (CP Edition)," the quality standards for pharmaceutical-grade potassium citrate cover multiple aspects to ensure its safety, efficacy, and stability in medications.

1. Appearance and Properties

Pharmaceutical-grade potassium citrate should appear as a white crystalline powder or granules, odorless or with a slight acidic odor. Its appearance must be clean and free of visible impurities. Solubility requirements include:

- Solubility: Easily soluble in water, almost insoluble in ethanol.

- Solution Clarity: The aqueous solution must be clear and transparent without significant precipitation.



Main products include:
Common excipients for topical preparations: Glycerin/Propylene Glycol, Vaseline/Lanolin, Laurocapram, Stearic Acid, Triethanolamine, Poloxamer 188/407, Polysorbate 80, Polyethylene Glycol Series, Solid Paraffin, Liquid Paraffin (Light/Heavy), Mixed Fatty Acid Glycerides, and other varieties.
Excipients for oral preparations: Honey/Sucrose, Lactose/Aspartame, Hydroxypropyl Beta-Cyclodextrin, Hypromellose, Methylcellulose, Ethylcellulose, Microcrystalline Cellulose, Povidone K30, Magnesium Stearate, Maltose/Saccharin Sodium/Sucralose/Tranexamic Acid/Stevioside, Gelatin, Color Lakes, Flavors, and other varieties.
Excipients for injections: (Endotoxin & Microbial Limit Requirements)
Cholesterol, Trehalose (Anhydrous/Dihydrate), Lecithin/Soybean Phospholipid, Polysorbate (for injection), Citric Acid/Sodium Citrate, Sodium Phosphate Monobasic/Potassium Phosphate Dibasic, Lactose (for injection), Disodium Edetate (for injection)
Raw materials for topical disinfection and antibacterial use:
Chlorhexidine Acetate, Chlorhexidine Gluconate Solution, Benzalkonium Bromide/Benzalkonium Chloride, Menthol/Mentha Arvensis Oil, Salicylic Acid/Sodium Benzoate, Vitamin E Oil, Dimethicone, Span 80/85, Methylparaben/Ethylparaben/Propylparaben/Sodium Methylparaben/Sodium Propylparaben, Tromethamine, Chlorobutanol, Aluminum Glycinate, etc.


Sterile Water for Injection, Silver Sulfadiazine, Vitamin A, Camphor, Borneol, Sodium Bicarbonate, Berberine, Pentoxyverine Citrate, Metformin, Artificial Cow Bezoar, Paracetamol, Simple Syrup, Dexamethasone, Glycerin, Potassium Citrate, Chitosan, Calamine, Roxithromycin, Procaine
Also available for consultation: Food-grade products, extracts, reagents, intermediates, cosmetic raw materials, and export products.


Industry Category Chemicals
Product Category
Brand: 华日
Spec: 500g/瓶
Stock: 8900
Manufacturer:
Origin: China / Shaanxi / Xianshi
About Toocle.com - Partner Programme - Old Version
Copyright © Toocle.com. All Rights Reserved.
(浙)-经营性-2023-0192